🇺🇸 FDA
Pipeline program

temozolomide

F020522015

Phase 2 small_molecule completed

Quick answer

temozolomide for Cancer is a Phase 2 program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).

Program details

Company
INTEGRATED BIOPHARMA INC
Indication
Cancer
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials